N |
9506 |
5218 |
4288 |
|
Conditions |
High cholesterol, n (%)
|
2634 (27.71) |
1356 (26.00) |
1278 (29.80) |
<0.0001 |
Heart attack/angina, n (%)
|
604 (6.35) |
287 (5.50) |
317 (7.39) |
0.0002 |
Hypertension, n (%)
|
2845 (29.93) |
1400 (26.85) |
1445 (33.70) |
<0.0001 |
Diabetes, n (%)
|
899 (9.46) |
423 (8.11) |
476 (11.10) |
<0.0001 |
Underactive/overactive thyroid, thyroiditis, n (%)
|
369 (3.88) |
185 (3.54) |
184 (4.29) |
0.0608 |
Stroke, n (%)
|
271 (2.85) |
142 (2.72) |
129 (3.01) |
0.4045 |
Multiple sclerosis, n (%)
|
18 (0.19) |
10 (0.19) |
8 (0.19) |
0.9551 |
Irritable bowel syndrome, n (%)
|
963 (10.13) |
427 (8.19) |
536 (12.50) |
<0.0001 |
Fibromyalgia, n (%)
|
246 (2.59) |
68 (1.30) |
178 (4.15) |
<0.0001 |
Chronic fatigue syndrome, n (%)
|
133 (1.40) |
55 (1.05) |
78 (1.82) |
0.0016 |
Chronic obstructive pulmonary disease (COPD), n (%)
|
103 (1.08) |
54 (1.03) |
49 (1.14) |
0.6126 |
Asthma, n (%)
|
412 (4.33) |
212 (4.06) |
200 (4.66) |
0.1514 |
Idiopathic pulmonary fibrosis, n (%)
|
3 (0.03) |
3 (0.06) |
0 (0.00) |
0.1164 |
Liver cirrhosis, n (%)
|
6 (0.06) |
4 (0.08) |
2 (0.05) |
0.5622 |
Hepatitis, n (%)
|
5 (0.05) |
2 (0.04) |
3 (0.07) |
0.5031 |
Non-alcoholic fatty liver disease, n (%)
|
6 (0.06) |
4 (0.08) |
2 (0.05) |
0.5622 |
Rheumatoid arthritis, n (%)
|
92 (0.97) |
25 (0.48) |
67 (1.56) |
<0.0001 |
Ankylosing spondylitis, n (%)
|
19 (0.20) |
3 (0.06) |
16 (0.37) |
0.0006 |
Lupus, n (%)
|
12 (0.13) |
4 (0.08) |
8 (0.19) |
0.1331 |
Psoriatic arthritis, n (%)
|
17 (0.18) |
4 (0.08) |
13 (0.30) |
0.0093 |
Systems affected |
Cardiovascular disease, n (%) |
4124 (43.38) |
2105 (40.34) |
2019 (47.08) |
<0.0001 |
Endocrine disease, n (%) |
1229 (12.93) |
595 (11.40) |
634 (14.79) |
<0.0001 |
Non-restorative pain disorders, n (%) |
1164 (12.24) |
497 (9.52) |
667 (15.56) |
<0.0001 |
Lung disease, n (%) |
497 (5.23) |
263 (5.04) |
234 (5.46) |
0.3624 |
Liver disease, n (%) |
17 (0.18) |
10 (0.19) |
7 (0.16) |
0.7447 |
Chronic kidney disease/failure (CKD), n (%) |
23 (0.24) |
8 (0.15) |
15 (0.35) |
0.0523 |
Central nervous system disorders, n (%) |
289 (3.04) |
152 (2.91) |
137 (3.19) |
0.4246 |
Gout, n (%) |
94 (0.99) |
54 (1.03) |
40 (0.93) |
0.6175 |
Chronic rheumatic conditions, n (%) |
138 (1.45) |
35 (0.67) |
103 (2.40) |
<0.0001 |
Comorbidity count |
N of comorbidities, mean (SD), n (%) |
0.80 (0.85) |
0.71 (0.81) |
0.90 (0.90) |
<0.0001 |
Any comorbidities, n (%) |
5355 (56.33) |
2740 (52.51) |
2615 (60.98) |
<0.0001 |
Any comorbidities ≥ 2, n (%) |
1804 (18.98) |
822 (15.75) |
982 (22.90) |
<0.0001 |
Any comorbidities ≥ 3, n (%) |
367 (3.86) |
137 (2.63) |
230 (5.36) |
<0.0001 |
Any comorbidities ≥ 4, n (%) |
45 (0.47) |
19 (0.36) |
26 (0.61) |
0.0868 |